HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heart transplantation in endstage rheumatic heart disease-experience of an endemic area.

AbstractBACKGROUND:
Rheumatic heart disease (RHD) remains a significant cause of cardiovascular disease in developing countries. The nonsuppurative cardiovascular sequel of group A streptococcal infection is sustained inflammatory and immune reactions toward the myocardium and valves. This study attempted to determine the long-term outcome of heart transplantation in endstage RHD patients.Methods and Results:The 23 patients with endstage RHD at National Taiwan University Hospital between June 1987 and March 2012 were enrolled. In the same period, 226 dilated cardiomyopathy (DCM) patients were enrolled as the control group. The RHD group experienced more right ventricular failure and higher central venous pressure than the control group, which resulted in impaired liver and kidney function. The RHD patients had a lower 15-year survival rate than the DCM patients after transplantation (22.7% vs. 45.7%, P=0.038) and higher incidence of tricuspid regurgitation than the control group (32.2% vs. 11.4%). No differences existed between the groups for the mitral regurgitation rate (RHD 37.7% vs. DCM 29.4%, P=0.562).
CONCLUSIONS:
Preoperatively, the RHD patients suffered more tricuspid regurgitation than the control group. The aortic and mitral valves in both groups functioned well over the long term. Heart transplantation for endstage RHD had a long-term survival rate that was inferior to that for DCM patients.
AuthorsNai-Hsin Chi, Nai-Kuan Chou, Ya-Hui Yu, Hsi-Yu Yu, I-Hui Wu, Yih-Sharng Chen, Shu-Chien Huang, Wen-Je Ko, Shoei-Shen Wang
JournalCirculation journal : official journal of the Japanese Circulation Society (Circ J) Vol. 78 Issue 8 Pg. 1900-7 ( 2014) ISSN: 1347-4820 [Electronic] Japan
PMID24965078 (Publication Type: Journal Article)
Topics
  • Adult
  • Disease-Free Survival
  • Endemic Diseases
  • Female
  • Heart Transplantation
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Rheumatic Heart Disease (mortality, surgery)
  • Survival Rate
  • Taiwan (epidemiology)
  • Ventricular Dysfunction, Right (etiology, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: